Express Scripts (ESRX) investors need to consider some of the risks in buying shares of the company. In this video, Fool Jim Mueller outlines three risks to the company's future health. Acquisitions, for example, may be more difficult to come by as Express Scripts could be viewed as having a monopoly on the pharmacy management business. Will the economy discourage new customers? Will synergies be achieved with its acquisitions? Investors need to think about these matters before jumping in.
S&P 500
6,000.36
+1.0%
+$61.06
DJI
42,762.87
+1.0%
+$443.13
NASDAQ
19,529.95
+1.2%
+$231.50
Bitcoin
105,505.00
+0.4%
+444.90
AAPL
$204.23
+1.8%
+$3.60
AMZN
$213.68
+2.8%
+$5.77
GOOG
$174.93
+3.0%
+$5.12
META
$698.00
+2.0%
+$13.38
MSFT
$470.38
+0.6%
+$2.70
NVDA
$141.76
+1.3%
+$1.77
TSLA
$295.66
+3.8%
+$10.96
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.